BAYN N Stock Overview
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Bayer Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €541.80 |
52 Week High | €1,133.07 |
52 Week Low | €541.80 |
Beta | 0.97 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -54.46% |
3 Year Change | -59.11% |
5 Year Change | -58.67% |
Change since IPO | -70.12% |
Recent News & Updates
Recent updates
Shareholder Returns
BAYN N | MX Pharmaceuticals | MX Market | |
---|---|---|---|
7D | 0% | 1.5% | 2.3% |
1Y | -54.5% | -16.8% | 2.7% |
Return vs Industry: BAYN N underperformed the MX Pharmaceuticals industry which returned -16.8% over the past year.
Return vs Market: BAYN N underperformed the MX Market which returned 2.7% over the past year.
Price Volatility
BAYN N volatility | |
---|---|
BAYN N Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 3.8% |
10% most volatile stocks in MX Market | 6.1% |
10% least volatile stocks in MX Market | 1.9% |
Stable Share Price: BAYN N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BAYN N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1863 | 96,931 | Bill Anderson | www.bayer.com |
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Bayer Aktiengesellschaft Fundamentals Summary
BAYN N fundamental statistics | |
---|---|
Market cap | Mex$493.75b |
Earnings (TTM) | -Mex$53.95b |
Revenue (TTM) | Mex$873.78b |
0.6x
P/S Ratio-9.2x
P/E RatioIs BAYN N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BAYN N income statement (TTM) | |
---|---|
Revenue | €47.64b |
Cost of Revenue | €19.75b |
Gross Profit | €27.89b |
Other Expenses | €30.83b |
Earnings | -€2.94b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
Earnings per share (EPS) | -2.99 |
Gross Margin | 58.55% |
Net Profit Margin | -6.17% |
Debt/Equity Ratio | 132.3% |
How did BAYN N perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-4%
Payout RatioDoes BAYN N pay a reliable dividends?
See BAYN N dividend history and benchmarksBayer dividend dates | |
---|---|
Ex Dividend Date | Apr 29 2024 |
Dividend Pay Date | May 02 2024 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 2 days |
Does BAYN N pay a reliable dividends?
See BAYN N dividend history and benchmarks